Clinical Trial Update: TMC435-TiDP16-C108 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and Digoxin and Between TMC435 and Rosuvastatin [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers assessing the pharmacokinetic interactions between TMC435 and digoxin and between TMC435 and rosuvastatin; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• DIGOXIN (Digoxin)
• Rosuvastatin (rosuvastatin)
• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED